Base Editing: Putting Precision into Genomic Medicine

During this presentation, which is part of TriLink BioTechnologies gene editing and cell therapy webinar series, Dr. Gaudelli will discuss how her group has transformed off-the-shelf base editors from a technology developed in academia to a promising therapeutic tool through engineering, screening, and directed evolution.
Illustration of amyloid plaques on a nerverticale cell

Unlocking the Drivers of Neuroinflammation in Neurodegenerative Disease

In this GEN webinar, sponsored by 10x Genomics, Dr. Katerina Akassoglou of the Gladstone Institutes will address the gaps in our understanding and treatment of neuroinflammation.
DNA molecule, illustration

Association to Causation: Using GWAS to Identify Druggable Targets

In this GEN webinar, sponsored by Synthego, we will discuss the development of a fully automated genome engineering platform that empowers large scale functional investigation of disease-associated variants to identify the causal variants and causal genes, in a cost- and time-effective manner.

Data-Driven Insights on Cell Therapy Fill and Finish Processes

In this GEN webinar, sponsored by Terumo BCT, we hear from a team of scientists who will discuss the parameters for the fill/finish and cryopreservation steps of a cell therapy manufacturing process. We will also looked at data from a typical manual fill and finish process compared to data from an automated process using the Finia® Fill and Finish System.
Genetic engineering, conceptual illustration

Tackling Disease with iPSCs and Genome Editing

In this GEN webinar, sponsored by Horizon Discovery, we will provide a field overview of how iPSCs, coupled with genome editing, hold the potential to expand our understanding of human diseases further, and facilitate the development of new therapies.

The Future of Cellular Immunotherapy: Highly Automated Precision Medicine

In this GEN webinar, learn how Lonza’s Cocoon™ cell therapy manufacturing platform and IsoPlexis’ IsoLight™ single-cell proteomics system can be used together to advance the future of cancer immunotherapy.

Recently Featured

Scroll Up